Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296766430> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4296766430 endingPage "2870" @default.
- W4296766430 startingPage "2870" @default.
- W4296766430 abstract "<h3>Objective.</h3> —To assess current use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation at US hospitals that participate in the training of pulmonary fellows. <h3>Design.</h3> —Surveys were mailed in September 1990 to the head nurses of medical intensive care units at 265 US hospitals that were listed in an annual guide listing pulmonary fellowship training programs. In the survey, sedating drugs were defined as medications prescribed to treat anxiety, agitation, or sleeplessness. These included opiates, anesthetics, or neuroleptic agents when used for any of these purposes. <h3>Survey Respondents.</h3> —Surveys were received from nurses at 164 hospitals (62% response rate) representing 93 medical schools and 100 pulmonary fellowship training programs. Nearly half of the respondents worked at university hospitals. Most worked as head nurses in medical (70%) or medical-surgical (21%) intensive care units (ICUs). <h3>Results.</h3> —Sedating drugs were given to patients undergoing mechanical ventilation at virtually all the ICUs surveyed, and 36% used these drugs routinely (>70% of patients). Opiates and benzodiazepines were employed most commonly; haloperidol lactate was widely used as well. Intermittent intravenous injection was the preferred method of administration; 62% of the ICUs also gave these drugs by continuous intravenous infusion. Neuromuscular blocking agents were also used at nearly all the ICUs surveyed; however, most gave these drugs to fewer than 20% of patients experiencing respiratory failure. Orders for the use of sedating drugs and neuromuscular blocking agents were written exclusively by house staff at 65% of the ICUs surveyed. <h3>Conclusions.</h3> —Sedating drugs and neuromuscular blocking agents are widely used for patients requiring mechanical ventilation in ICUs at US teaching hospitals. There is considerable variation in the choice, frequency, and method of administration. Given the expense (up to $1000 a day) and the potential hazards to patients of prolonged deep sedation and paralysis, more research is warranted to determine optimal use of these drugs during mechanical ventilation. (<i>JAMA</i>. 1991;266:2870-2875)" @default.
- W4296766430 created "2022-09-23" @default.
- W4296766430 creator A5010472993 @default.
- W4296766430 date "1991-11-27" @default.
- W4296766430 modified "2023-09-26" @default.
- W4296766430 title "Use of Sedating Drugs and Neuromuscular Blocking Agents in Patients Requiring Mechanical Ventilation for Respiratory Failure" @default.
- W4296766430 doi "https://doi.org/10.1001/jama.1991.03470200082040" @default.
- W4296766430 hasPublicationYear "1991" @default.
- W4296766430 type Work @default.
- W4296766430 citedByCount "178" @default.
- W4296766430 countsByYear W42967664302012 @default.
- W4296766430 countsByYear W42967664302013 @default.
- W4296766430 countsByYear W42967664302014 @default.
- W4296766430 countsByYear W42967664302015 @default.
- W4296766430 countsByYear W42967664302016 @default.
- W4296766430 countsByYear W42967664302017 @default.
- W4296766430 countsByYear W42967664302018 @default.
- W4296766430 countsByYear W42967664302019 @default.
- W4296766430 countsByYear W42967664302020 @default.
- W4296766430 countsByYear W42967664302021 @default.
- W4296766430 countsByYear W42967664302022 @default.
- W4296766430 countsByYear W42967664302023 @default.
- W4296766430 crossrefType "journal-article" @default.
- W4296766430 hasAuthorship W4296766430A5010472993 @default.
- W4296766430 hasConcept C177713679 @default.
- W4296766430 hasConcept C194828623 @default.
- W4296766430 hasConcept C2777080012 @default.
- W4296766430 hasConcept C2910841738 @default.
- W4296766430 hasConcept C2987404301 @default.
- W4296766430 hasConcept C42219234 @default.
- W4296766430 hasConcept C71924100 @default.
- W4296766430 hasConceptScore W4296766430C177713679 @default.
- W4296766430 hasConceptScore W4296766430C194828623 @default.
- W4296766430 hasConceptScore W4296766430C2777080012 @default.
- W4296766430 hasConceptScore W4296766430C2910841738 @default.
- W4296766430 hasConceptScore W4296766430C2987404301 @default.
- W4296766430 hasConceptScore W4296766430C42219234 @default.
- W4296766430 hasConceptScore W4296766430C71924100 @default.
- W4296766430 hasIssue "20" @default.
- W4296766430 hasLocation W42967664301 @default.
- W4296766430 hasOpenAccess W4296766430 @default.
- W4296766430 hasPrimaryLocation W42967664301 @default.
- W4296766430 hasRelatedWork W1966539464 @default.
- W4296766430 hasRelatedWork W2019049609 @default.
- W4296766430 hasRelatedWork W2022106209 @default.
- W4296766430 hasRelatedWork W2085461880 @default.
- W4296766430 hasRelatedWork W2158989862 @default.
- W4296766430 hasRelatedWork W2397171669 @default.
- W4296766430 hasRelatedWork W28070334 @default.
- W4296766430 hasRelatedWork W3036560036 @default.
- W4296766430 hasRelatedWork W3080320545 @default.
- W4296766430 hasRelatedWork W4244897591 @default.
- W4296766430 hasVolume "266" @default.
- W4296766430 isParatext "false" @default.
- W4296766430 isRetracted "false" @default.
- W4296766430 workType "article" @default.